Join to View Full Profile
9200 W Wisconsin Ave# NeoplastMilwaukee, WI 53226
Phone+1 414-805-0700
Fax+1 414-805-0714
Dr. Horowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1987 - 1989- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1980 - 1984
- Medical College of WisconsinClass of 1980
Certifications & Licensure
WI State Medical License 1981 - 2027
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) Start of enrollment: 2008 Oct 01
Publications & Presentations
PubMed
- 2 citationsCHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.Andrew S Artz, Brent Logan, Wael Saber, Nancy Geller, Anna Bellach
Blood Advances. 2026-03-10 - 2 citationsAccess to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine
Transplantation and Cellular Therapy. 2026-03-01 - Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.Jakob Wirbel, Wael Saber, Michael J Martens, Jonathan U Peled, Tessa M Andermann
Biorxiv. 2026-02-19
Journal Articles
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Abstracts/Posters
- Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lympho...Mary M. Horowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...Mary M. Horowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- BMT CTN Protocol 1506: A Phase 3 Trial of Gilteritinib As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3-ITD+ AMLMary M. Horowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Annual NMDP(SM) Gala in New York City Raises over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell TherapyMay 6th, 2025- Ryght AI Welcomes the Medical College of Wisconsin to Global Site Network as Their Latest Academic PartnerApril 3rd, 2025
- Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicineMay 24th, 2023
Grant Support
- Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.MEDICAL COLLEGE OF WISCONSIN2017–2031
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- A Data Resource For Analyzing Blood And Marrow TransplantsNational Cancer Institute2008–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
